Authors
Broyan T.S.1, 2, Kalinin R.E.1, Suchkov I.A. 1, Mzhavanadze N.D.1, Povarov V.O.1, Suchkov D.I.1, Golubenko V.L.2, Nikiforov A.A.1, Nikiforova L.V.1
1 Ryazan State Medical University, Ryazan
2 Novomoskovsk City Clinical Hospital, Novomoskovsk
Abstract
Introduction. Coronary artery disease (CAD) is known to be the most common cause of death worldwide. The most widespread surgical treatment for CAD is percutaneous coronary intervention (PCI), which involves intravascular procedures that can lead to blood coagulation disorders, increasing the risk of intraoperative and postoperative complications. The most severe complications of PCI are thrombotic events, which remain the leading cause of early postoperative morbidity and mortality.
Objective. To evaluate the impact of von Willebrand factor (vWF), coagulation factor VIII (FVIII), and the metalloprotease ADAMTS-13 on the occurrence of thrombotic complications during coronary interventions.
Materials and methods. This single-center prospective cohort study included 143 patients with stable CAD, acute coronary syndrome (ACS), and patients with a suspected diagnosis of CAD. Each patient with clinical manifestations of CAD underwent coronary angiography; PCI was performed when indicated. Participants were divided into three groups. Group A included 50 patients with chronic forms of CAD who underwent coronary angiography and subsequent stenting. Group B included 50 patients with ACS and stenting. Group C included 43 patients with clinical suspicion of CAD but no hemodynamically significant coronary artery stenoses found on angiography. Peripheral venous blood samples were taken from all three groups at three time points: before the procedure, 24 hours after, and 30 days after the intervention. Levels of vWF, FVIII, and ADAMTS-13 were assessed.
Results. Statistically significant differences in vWF and FVIII levels were found in all examined patients across the three time points: before endovascular intervention, 24 hours after, and one month later. No significant differences in ADAMTS13 levels were observed across the three time points. In Group A, a statistically significant difference in vWF levels was found between pre operative values and values obtained 30 days after the procedure (p = 0.032). In Group C, significant differences in vWF levels were observed before the procedure versus 24 hours after (p = 0.004), and before the procedure versus 30 days after (p = 0.012). For FVIII levels, statistically significant differences were observed before versus 24 hours after the procedure (p = 0.002), and before the intervention versus one month after (p = 0.006). Regarding outcomes, the incidence of radial artery occlusion (RAO), stent thrombosis (ST), myocardial infarction (MI), and limb artery thrombosis was low, with no statistically significant differences between groups. The most frequent thrombotic event was RAO, observed in 5.6% of the study participants. According to multivariate regression analysis, significant independent predictors of RAO were elevated baseline FVIII level and female sex.
Conclusions
1. Patients undergoing coronary angiography and PCI show a statistically significant and sustained increase in vWF and FVIII levels. ADAMTS-13 levels did not change significantly.
2. The most pronounced increase in vWF at 24 hours after the intervention was recorded in patients without hemodynamically significant coronary artery stenoses, which may indicate higher sensitivity of intact endothelium to mechanical injury.
3. The incidence of radial artery occlusion in the study cohort was 5.6%.
4. Independent risk factors for RAO after transradial interventions were elevated FVIII level before radial artery puncture and female sex.
5. Determination of baseline FVIII level before coronary angiography and PCI may be recommended as a method for RAO risk stratification, particularly in female patients.
Keywords: Percutaneous coronary intervention, coronary angiography, von Willebrand factor, factor VIII, ADAMTS-13, thrombotic complications, radial artery occlusion.
References
1. Barr PR, Harrison W, Smyth D, et al. Myocardial Infarction Without Obstructive Coronary Artery Disease is Not a Benign Condition (ANZACS-QI 10). Heart Lung Circ. 2018; 27(2): 165-174. doi: 10.1016/j.hlc.2017.02.023.
2. Glenza A, Dobrynina NV, Yakushin SS. Study of Some Predictors of Atherosclerosis in Persons with Elevated Blood Pressure and in Patients with Essential Hypertension in the Population of a Region with a High Mortality Rate. Science of the young (Eruditio Juvenium). 2024; 12(2): 221-228. (In Russ.) doi: 10.23888/HMJ2024122221-228.
3. Khandait H, Sachdeva S, Patel A, et al. Multivessel versus culprit vessel only percutaneous coronary intervention in non-ST elevation myocardial infarction: Systematic review and meta-analysis. Medicine (Baltimore). 2025; 104(22): e42527. doi: 10.1097/MD.0000000000042527.
4. Shevchenko YL, Ermakov DY, Marchak DI, Ulbashev DS, et al. Immediate and long-term outcomes of repeated endovascular correction of bifurcation lesions of coronary arteries. I.P. Pavlov Russian Medical Biological Herald. 2025; 33(3): 323-334. (In Russ.) doi: 10.17816/PAVLOVJ643477.
5. Malik TF, Tivakaran VS. Percutaneous Transluminal Coronary Angioplasty (Archived). 2023 Feb 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan.
6. De Pablo-Moreno JA, Serrano LJ, Revuelta L, Sánchez MJ, et al. The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V. Int J Mol Sci. 2022; 23(15): 8283. doi: 10.3390/ijms23158283.
7. Franz-Josef N, Miguel S-U, Anders A, et al. ESC Scientific Document Group, 2018 ESC/EACTS Guidelines on myocardial revascularization European Heart Journal. 2019; 40(2): 87-165. doi: 10.1093/eurheartj/ehy394.
8. Koo BK, Hu X, Kang J, et al. FLAVOUR Investigators. Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI. N Engl J Med. 2022; 387(9): 779-789. doi: 10.1056/NEJMoa2201546.
9. Naß J, Terglane J, Gerke V. Weibel Palade Bodies: Unique Secretory Organelles of Endothelial Cells that Control Blood Vessel Homeostasis. Front. Cell Dev. Biol. 2021; 9: 813995. doi: 10.3389/fcell.2021.813995.
10. Theofilis P, Sagris M, Oikonomou E, et al. Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches. Int J Mol Sci. 2022; 23(6): 3301. doi: 10.3390/ijms23063301.
11. Rashid M, Kwok CS, Pancholy S, et al. Radial Artery Occlusion After Transradial Interventions: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2016; 5(1): e002686. doi: 10.1161/JAHA.115.002686.
12. Alp C, Kandemir H, Ozturk S. Biomarker-based prediction of radial artery occlusion after cardiac catheterization. Braz J Med Biol Res. 2026; 59: e15093. doi: 10.1590/1414-431X2025e15093.
13. Rumley A, Lowe GDO, Sweetnam PM, et al. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Study. Br J Haematol. 1999; 105: 110-116.
14. Zakai NA, Judd SE, Kissela B, Howard G, et al. Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS). Thromb Haemost. 2018; 118(7): 1305-1315. doi: 10.1055/s-0038-1655766.


